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A B S T R A C T
Epilepsy surgery is common in the face of benign brain tumors, but rarely for patients with a history of
malignant brain tumors. Seizures are a common sequelae in survivors of malignant pediatric brain
tumors. Medical management alone may not adequately treat epilepsy, including in this group. We
report four cases of patients who previously underwent gross total resection, radiation therapy, and
chemotherapy for successful treatment of malignant brain neoplasia, yet suffered from medically
intractable seizures. All underwent surgery for treatment of epilepsy with extension of the original
resection. Despite the aggressive primary treatment of the neoplasm, and the potential for diffuse
cerebral insults, all beneﬁted from focal surgical resection. Aggressive surgical management of
intractable epilepsy can be considered in survivors of malignant brain tumors.
 2012 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at SciVerse ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Supratentorial brain tumors in the pediatric and adult
population are frequently associated with seizures.1,2 The fre-
quency is higher among low grade tumors (60–85%) than among
high grade tumors 20–40%.3–13 Although treatment with initial
anticonvulsants and surgery may be sufﬁcient to prevent long-
term epilepsy,9,14,15 recurrent seizures occur7,16 often in the
setting of tumor recurrence.10,17 Repeated seizures, refractory to
medical management, has been reported in 14–20% of patients
with primary brain tumors.9,14,18
Surgery for epilepsy in the setting of current, or previously
treated, low grade gliomas is a commonstrategy.4,11,19–22 When an
epileptic focus is identiﬁed, surgery is considered in the setting of
persistent epilepsy,23,24 with a rationale for even earlier identiﬁ-
cation of intractability when associated with a structural
lesion.19,25 In appropriate candidates, surgical removal of epileptic* Corresponding author at: Department of Neurological Surgery, University of
Washington, 4800 Sand Point Wy NE, W-7759, United States. Tel.: +1 206 987 4240;
fax: +1 206 987 3925.
E-mail address: jojemann@uw.edu (J.G. Ojemann).
1059-1311/$ – see front matter  2012 British Epilepsy Association. Published by Else
http://dx.doi.org/10.1016/j.seizure.2012.07.003foci is superior to medication alone26 in providing seizure freedom.
Other options for therapy, such as additional medication, poly-
therapy, and vagus nerve stimulation, may be palliative but have a
much lower seizure cure rate than surgery in patients with focal
onset.27 Surgical treatment of tumors for epilepsy may use
electrophysiology to maximize seizure outcomes28,29 though this
is not always employed.16
Patients with high-grade tumors are less often operated on
solely for control of their seizure disorder, perhaps because of the
decreased length of expected survival. Certainly, such patients are
uncommon. Malignant gliomas represented a minority of patients
with temporal lobe tumors presenting with seizures to a large
referral center30 and appear nearly absent from major pediatric
epilepsy series.20 Additionally, the need for therapies, such as
radiation therapy and chemotherapy, that increase the risk of
diffuse cerebral insult could, in theory, make these patients poorer
candidates for focal resection to ameliorate their seizures.
We present four cases of patients who survived malignant
primary brain tumors, in the pediatric setting, after aggressive
surgery and adjuvant therapy, but developed medically intractable
seizures. All underwent focal resection for their epilepsy, including
the region of previous surgery. They responded well with seizure
control and no new apparent neurological deﬁcits. Seizurevier Ltd. All rights reserved.
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Medical records were reviewed according to a protocol approved
by the Institutional Review Board of Seattle Children’s Hospital.
2. Case 1
A 23-year old underwent gross total resection of a right
frontal astrocytoma (grade III) after presenting at age 3 with
developmental delay. He received whole brain radiation therapy
and chemotherapy (lomustine, vincristine, hydroxyurea, procar-
bazine, cisplatin, cytosine arabinoside, dacarbazine, and meth-
ylprednisolone). He developed progressive seizures over the
subsequent years and underwent a repeat surgery at age 9 for
seizures and a concern for residual tumor. The seizure recurred,
evolving to a frequency of twice daily, characterized by staring,
left facial drop, interruption of speech and unusual behaviors
such as repeated jumping, climbing, and going to the wash room.Fig. 1. (A) MRI scan of case 1 showing the old right frontal resection cavity and multiple 
changes were found throughout both hemispheres. (B) Scalp EEG recording at the beginn
the right (*), consistent with seizures arising from the vicinity of his previous resectionHe remained poorly controlled on therapeutic doses of carba-
mazepine, lamotrigine, and levetiracetam. His history was
notable for hypopituitarism (anterior) related to radiation
therapy. He had cognitive delay but was employed part-time,
participated in Special Olympics, and was without focal
neurologic ﬁndings. Neuropsychological testing demonstrated
an IQ of 58 with global cognitive impairment. MRI revealed
bilateral white matter changes along with encephalomalacia in
the region of his original right frontal resection (Fig. 1A). These
white matter changes had been stable over several years and no
evidence of recurrent tumor seen. A cavernous malformation
was seen in the periventricular region posterior to the resection
cavity.
Interictal EEG demonstrated frequent spike-wave discharges
that were more over the right frontal lobe (Fig. 1B). Ictal EEG and ictal
SPECT also suggested a right frontal focus. He underwent repeat
right frontal craniotomy for resection of epileptogenic focus, usingsubcortical regions with increased T2 weighted changes. These non-speciﬁc diffuse
ing of a typical seizure. Changes seen early over both frontal lobes were stronger on
.
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navigation. The central sulcus was localized using median nerve
evoked potentials33 and cortical stimulation mapping.34,35
Electrocorticography showed interictal activity over the pos-
terolateral and superomedial right frontal lobe, extending medial
and posterior to the previous surgical site, but in front of motor
cortex. The resection was carried out posterior to the previous
surgical cavity and taken to the ventricle and then medially to the
falx, completing a right superior frontal disconnection. Pathology
revealed only a hypervascular scar with no neoplasm. Post-
operatively, he had mild left arm weakness that recovered with a
short course of outpatient occupational and physical therapy. He
returned to work and had only rare seizures (Class II) for over 2Fig. 2. (A) MRI scan of case 2 shows the resection cavity from a large parietal choroid 
frequent, focal discharges over the left frontal-central regions (**).years until medication changes were associated with some
recurrence (Class III) of events at a lower rate.
3. Case 2
This child presented with hydrocephalus and a large left
posterior intraventricular tumor at 3 months of age. He underwent
gross total resection of a choroids plexus carcinoma (Fig. 2A) and
was diagnosed, after resection of an adrenal cortical carcinoma,
with Li-Fraumeni syndrome. He received chemotherapy (PBTC-
012, cilengitide prior to etoposide but progressed to etoposide
alone), after relapse several months later (initial chemotherapy
had been declined), with response. He had no recurrence on serialplexus carcinoma. No evidence of recurrence was seen. (B) The scalp EEG showed
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tively and, at age 3 years, continued to have ten events per day
despite therapeutic levels of topiramate, zonisamide, and clonaz-
epam. Treatment with ACTH provided no beneﬁt. Extensive herbal
supplements including cod liver oil, Agaricus Blazei, Green Tea
extract, vitamins D and K2, and enemas of shark cartilage were also
employed by the family during his care. He had not developed
expressive speech and understood few simple commands. He had a
right hemiparesis and appeared to have a right sided neglect and/
or visual ﬁeld deﬁcit.Fig. 3. (A) MRI scan of case 3 with a gross total resection of an atypical teratoid-rhabdoid
occurred nearly continuously (seen in leads marked by *) and evolved into seizures seEEG demonstrated multifocal spikes over the left hemisphere,
especially the left central region (Fig. 2B), with focal slowing over
the left temporal, occipital and central regions. He had multiple
epileptic spasms, without focal features, during a routine study.
Because of the lateralized nature of his EEG ﬁndings and the
presence of lateralized neurological deﬁcit, a hemispherectomy was
recommended. He underwent disconnective hemispherotomy36
with ventricular drainage. This procedure includes resection of the
hippocampus and residual temporal lobe along with disconnection
of remaining central and frontal cortex. Pathology showed only tumor, again without evidence of recurrence. (B) Focal right frontal discharges that
veral times a day with behavioral effects.
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tion was unchanged post-operatively and he developed expressive
speech within 2 months of surgery. He had no further seizures and
demonstrated accelerated language development, being seizure free
(Class Ia), taking no anticonvulsant medication, at 4 years post-
operative follow-up.
4. Case 3
A 6-year-old boy presented at 2 years of age with vomiting and
was diagnosed with a right frontal atypical-teratoid rhabdoid
tumor and underwent gross total resection (Fig. 3A). He received
focal radiation (5040 cGy) and chemotherapy (under CCG-99703,Fig. 4. (A) MRI scan of case 4 with a resection cavity after removal of an anaplastic oligode
asynchronous background with right greater than left attenuation, demonstrating righcisplatin, etoposide cyclophosphamide and vincristine followed by
thiotepa and carboplatin and stem cell rescue). He developed
seizures 2 years post operative, characterized by behavioral arrest
with subsequent left arm ﬂexion, hand dystonia, and throat clonus.
Seizures lasted 20 s to 1 min with a rapid return to baseline. He
failed multiple mediations and continued to have 10–40 seizures
per day while treated with oxcarbazepine, lamotrigine, and
levetiracetam. He had become less interactive with increasing
seizure frequency and had slightly less use of his left hand.
Interictal EEG demonstrated frequent stretches of subclinical
continuous spike-wave activity (1–2 spikes/s) in the right frontal
region (Fig. 3B) along with right frontotemporal slowing. Seizure
onset was seen electrically up to 2 s before the clinical event.ndroglioma. (B). Scalp EEG of a hemi-tonic seizure with secondary generalization on
t hemispheric onset of the seizure. Right sided rhythmic activity is labeled (*).
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lobectomy with intraoperative electrocorticography. The central
sulcus was identiﬁed and conﬁrmed using intraoperative somato-
sensory evoked potentials. Intraoperative electrocorticography
was positive for diffuse spike wave activities through the lateral
frontal lobe, orbitofrontal lobe and medial frontal cortex and these
areas were disconnected or resected. The resection started 2–3 cm
in front of the motor cortex and continued down to the lateral
aspect of the ventricle, followed by disconnection of the medial
frontal cortex. The disconnection was completed along the orbital–
frontal cortex. Post-resection corticography was free of epilepti-
form activity. Pathology was free of neoplasm, showing gliosis
only. Post-operatively, he had mild worsening of his left hand
dexterity which recovered fully within 6 weeks. He had no seizures
and exhibited increasing alertness and communicativeness at 6
months follow-up and is now seizure free (Class Ia), on one
anticonvulsant, 3–1/2 years post-operative.
5. Case 4
A 2-year-old girl presented at 5 months of age with seizures
consisting of left arm jerking, increasing in frequency to several
times a day. A right temporal lobe lesion was evident on CT and
MRI (Fig. 4a). She underwent craniotomy for gross total resection
of anaplastic oligodendroglioma. She subsequently received
chemotherapy (Temozolomide). A month later she developed
infantile spasms that were poorly controlled by ACTH and
ketogenic diet. Interictal EEG showed multifocal epileptiform
discharges predominantly from right hemisphere. FDG-PET
demonstrated diffuse hypometabolism on the right side with
the spared right superior frontal area. MRI showed no change in the
tumor, though pseudo-progression of the tumor occurred while on
Vigabatrin and was reported.37 Her seizures continued despite
anticonvulsant medications including zonisamide, lamotrigine,
and ruﬁnamide. In addition to increasing frequency of seizures, the
child presented with signiﬁcant psychomotor delay (unable to sit
or crawl and absence of expressive language) in addition to left
hemiparesis.
Two years after her initial surgery, she underwent a right
functional hemispherectomy36 with ventricular drainage includ-
ing resection of the hippocampus and residual temporal lobe.
Adjacent to the initial resection, pathology was consistent with
recurrent/residual oligodendroglioma but with a much lower
grade neoplasm than originally, with less cellularity, lower mitotic
rate, and no endothelial proliferation. She has had only rare
seizures on 1-year follow-up (3 breakthrough seizures at the time
of viral illness when she was unable to take oral medication) and is
taking only lamotrigine for seizures. She has had slow develop-
ment, with gradual improvement of motor activity of the left
extremities and socially interactive, but with no speech. Follow-up
MRIs show no evidence of tumor.
6. Discussion
Surgical treatment for epilepsy associated with low-grade
tumor is well established either at the time of ﬁrst surgery or in the
setting of intractable epilepsy in survivors. High grade brain
tumors can be associated with epilepsy requiring aggressive
medical management,8,38–40 yet surgical options in survivors is
rarely reported, even in series focusing on brain tumors and
epilepsy.11–14,20 Unfortunately, seizure control appears to be
incomplete in many of these patients. In addition to the impact
of seizures on quality of life,6 medication side effects are also a
signiﬁcant concern.8,41
Interestingly, in some series, patients with higher-grade tumors
with long term epilepsy have shown better survival rates11,42suggesting that seizure could be over-represented in survivors.
Since one of the mechanisms hypothesized as associated with the
epileptogenicity of low grade tumor is a slow creation of dysplastic
or structural changes in adjacent brain tissue, this change takes
time and the natural course of the low grade (or more favorable)
tumor may make them more epileptogenic then high grade
tumor.4,5,8,41,43 Additionally, the longer survival of a less aggressive
tumor would give more time for epilepsy to develop.
In all of our patients, an aggressive approach to seizure control
was taken. All had maximal medical therapy. In all cases, the video
EEG was particularly helpful, capturing the epileptic events and
localizing the interictal and ictal abnormality to a region (frontal
lobe in two, one hemisphere in the other two) that was amenable
to surgical resection without unacceptable or unanticipated
morbidity. The non-dominant frontal lobe resection, kept in front
of motor cortex, and the hemispherectomy in the child with spastic
hemiplegia and visual ﬁeld deﬁcit were, in fact, well tolerated with
all cases showing improved overall function associated with the
resultant seizure control.
In other studies the occurrence of white matter changes
presenting as changes in the T2 signal were associated with the
development of intractable seizure.22 This may be a helpful sign in
surgical localization but, if focality was a correct assumption in our
case 1 (as his current outcome would suggest), these T2 changes
may over-represent the location of seizures, especially when
distant from the original peritumoral region.
Typically, post-operative seizures would give serious consider-
ation to a possible tumor recurrence,10,17 however only case #4
had imaging or histopathological evidence of recurrence. None of
the follow-up suggests recurrence thus it may be difﬁculty to
assign epileptogenicity only to the original tumor, original surgery,
chemotherapy, or diffuse radiation therapy, all of which could be
associated with seizures. There was no evidence of underlying
cortical dysplasia or other associated risk factor. Structural changes
were seen, but likely of the type present after any prior therapy.
In other series of reoperation for epilepsy, extension of the
original surgery is often the most effective approach.44 This
approach was, in broad terms, successful in this series suggesting
the original tumor insult was somehow relevant to the continued
seizures. In contrast, adjuvant therapy would be thought to be less
focal in its insult, thus a history of, for instance, radiation, would be
a theoretical argument against a focal treatment such as epilepsy
surgery, to treat seizures. This preliminary experience would argue
for a search for focal epilepsy, even in such a situation.
7. Summary
These cases suggest a potential role for second surgery for
seizure control in a select group of patients who develop medically
intractable epilepsy24 after surviving even high-grade primary
brain lesion of childhood. Once long-term survival is suggested,
surgical treatment of epilepsy should be a consideration for
improving quality of life.
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